Burzynski Research Institute

Recent papers from Burzynski Research Institute

1. Splashing and break-up of high-speed drops on wetted surfacesPhysics of Fluids · 2026
2. Recurrent Medulloblastoma: Complete Response and > than 21 Years and Five Months Overall Survival in a One-Year and Seven-Month-Old Male Treated with AntineoplastonsJournal of Oncology Research Review & Reports · 2023
3. Inoperable Optic Pathway Glioma: A Seven-Year-Old Male with >35 Years Overall Survival Following Treatment with AntineoplastonsEuropean Journal of Clinical Medicine · 2023
4. Newly Diagnosed Anaplastic Astrocytoma: > 23 Year Survival in a 31-Year and 11-Month-Old Female Treated with AntineoplastonsNeurology and Neuroscience · 2023
5. Newly Diagnosed Glioblastoma: Partial Response and > 27 Years Overall Survival in 37-Year-Old Male Treated with Antineoplastons (Treatment of Glioblastoma with Antineoplastons)Recent Advances in Clinical Trials · 2022
6. Outcomes in Four Children with Persistent, Recurrent, and Progressive Gangliogliomas Treated in Phase II Studies with Antineoplastons A10 and AS2-1Neurology and Neuroscience · 2022
7. A 25-year-female with Diffuse Intrinsic Pontine Glioma Surviving for More than Nine Years Following Treatment with AntineoplastonsInternational Journal of Clinical Oncology and Cancer Research · 2022
8. Effect of Nitrogen Doping on the Optical Bandgap and Electrical Conductivity of Nitrogen-Doped Reduced Graphene OxideMolecules · 2021
9. Long-Term Survival (27.7 Years) Following IV Antineoplaston Therapy (ANP) in a 36-Year-Old Female with a Progressive Diffuse Intrinsic Pontine Glioma (DIPG)International Journal of Radiology and Imaging Technology · 2021
10. A Review on Graphene-Based Light Emitting Functional DevicesMolecules · 2020
11. Boron-Doped Reduced Graphene Oxide with Tunable Bandgap and Enhanced Surface Plasmon ResonanceSHILAP Revista de lepidopterología · 2020
12. Pengukuran Kinerja Perbankan Dengan Metode CAMELAl-Mashrafiyah Jurnal Ekonomi Keuangan dan Perbankan Syariah · 2019
13. Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted TherapyCancer and Clinical Oncology · 2019
14. Development of Hysteresis Characteristics Model for Existing Wooden HousesJournal of Structural and Construction Engineering (Transactions of AIJ) · 2018
15. Antineoplastons A10 and AS2-1 in the Treatment of Children with Optic Pathway Glioma: Final Report for Protocol BT-23Cancer and Clinical Oncology · 2017
16. A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Low-Grade Astrocytomas—Final Report (Protocol BT-13)Journal of Cancer Therapy · 2016
17. Comprehensive Genomic Profiling of Recurrent Classic Glioblastoma in a Patient Surviving Eleven Years Following Antineoplaston TherapyCancer and Clinical Oncology · 2015
18. Long-Term Survival Over 21 Years and Pathologically Confirmed Complete Response in Pediatric Anaplastic Astrocytoma: A Case ReportJournal of Neurology & Stroke · 2015
19. A Phase II Study of Antineoplastons A10 and AS2-1 Injections in Adult Patients With Recurrent Anaplastic Astrocytoma—Final report (Protocol BT-15)Cancer and Clinical Oncology · 2015
20. A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Primary Brain Tumors—Final Report (Protocol BT-09)Journal of Cancer Therapy · 2015